Related Experiment Video
Updated: Jun 13, 2026
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Performance Improvement/Research Advisory Panel: a model for determining whether a project is a performance or
Lynn S Platteborze1, Stacey Young-McCaughan, Ileana King-Letzkus
1Regulatory Compliance and Quality Management, U.S. Army Institute of Surgical Research, 3400 Rawley E. Chambers Avenue, Fort Sam Houston, TX 78234-6315, USA.
Military Medicine
|May 8, 2010
Summary
Distinguishing between performance improvement and research is complex. A performance improvement/research advisory panel (PIRAP) was established to guide staff, differentiating activities and providing publication guidelines.
Area of Science:
- Clinical research ethics
- Healthcare quality improvement
- Regulatory compliance in healthcare
Background:
- Differentiating between performance improvement (PI) and research is challenging in academic clinical settings.
- Both PI and research share elements like scientific validity, participant selection, risk-benefit analysis, and independent review.
- Navigating regulatory requirements, including Institutional Review Board (IRB) review, adds complexity.
Purpose of the Study:
- To clarify the distinctions between performance improvement and research activities.
- To describe the formation and function of a performance improvement/research advisory panel (PIRAP).
- To provide guidelines for publishing findings based on the nature of the project (PI vs. research).
Main Methods:
- Formation of a performance improvement/research advisory panel (PIRAP) within two military healthcare organizations.
- Development of criteria to differentiate between PI and research activities.
- Establishment of guidelines for project classification and subsequent publication.
Main Results:
- The PIRAP provides a structured approach to classifying activities as either PI or research.
- Clearer differentiation aids in determining the appropriate regulatory oversight (e.g., IRB review).
- Guidelines facilitate appropriate dissemination of findings based on project classification.
Conclusions:
- A dedicated advisory panel can effectively guide staff in distinguishing PI from research.
- Accurate classification ensures compliance with relevant standards and regulations.
- Standardized guidelines support ethical conduct and appropriate scientific communication.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:19Quality Assurance
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:28Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...